Early research (Phase 1)Active Not RecruitingNCT06436742
What this trial is testing
A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS)
Who this might be right for
Congenital Myasthenic SyndromeCMS
argenx 15